Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 30 min ago
Peer-reviewedCC BY-NC-ND 4.0Scientific Reports

Association of pre-existing cardiovascular disease with cardiovascular and clinical outcomes in patients receiving immune checkpoint inhibitors

Related

  1. Association of Non‐Cytochrome P450 3A4‐Metabolized Statins Versus Atorvastatin With Major Adverse Cardiovascular Events in Patients With Cancer Receiving Tyrosine Kinase Inhibitors: A Propensity Score–Matched Target Trial Emulation
    Jing‐Huan Liao, Wei‐Cheng Chang, Hong‐Jie Jhou +3
    Journal of the American Heart AssociationPeer-reviewedCC BY-NC-NDOncologyCrossref
  2. Risk of de novo immune-related adverse events in patients with cancer and autoimmune disease receiving immune checkpoint inhibitors
    Rotana M. Radwan, Grant D. Scheiffele, Wenxi Huang +9
    Communications MedicinePeer-reviewedCC BY 4.0General medicineNatureCrossref
  3. The Dynamic Role of Liquid Biopsy in Patients with Non-Small Cell Lung Cancer Receiving Immune Checkpoint Inhibitors: Emerging Opportunities and Clinical Challenges
    Tancredi Didier Bazan Russo, Valerio Gristina, Francesco Pepe +13
    CancersPeer-reviewedCC BYFull textOncologyEurope PMCCrossref
  4. High-Sensitivity Cardiac Troponin T and I Discordance in Patients Receiving Immune Checkpoint Inhibitors
    Anis Ismail, Alexi Vasbinder, Bobby Bobby +14
    JACC: CardioOncologyPeer-reviewedCC BY 4.0Full text1 citedCardiovascular medicinePMCEurope PMC
  5. Distinct changes in plasma protein profiles of cancer patients receiving immune checkpoint inhibitors versus chemotherapy: implications for thrombosis risk and adverse outcomes
    Eleonora Camilleri, Nikola Vladic, Cornelia Englisch +10
    Research and Practice in Thrombosis and HaemostasisPeer-reviewedCC BYFull textOncologyDOAJ
BibTeX
@article{alfehaid2026association,
  title = {{Association of pre-existing cardiovascular disease with cardiovascular and clinical outcomes in patients receiving immune checkpoint inhibitors}},
  author = {Lama Alfehaid and Ahmed S. Alanazi and Mansour Alomran and Hadi Skouri and Nada Alsuhebany},
  journal = {Scientific Reports},
  year = {2026},
  month = oct,
  doi = {10.1038/s41598-026-74562-9},
  url = {https://www.nature.com/articles/s41598-026-74562-9},
  note = {CC BY-NC-ND 4.0},
}
RIS
TY  - JOUR
TI  - Association of pre-existing cardiovascular disease with cardiovascular and clinical outcomes in patients receiving immune checkpoint inhibitors
AU  - Lama Alfehaid
AU  - Ahmed S. Alanazi
AU  - Mansour Alomran
AU  - Hadi Skouri
AU  - Nada Alsuhebany
PY  - 2026
DA  - 2026/10/22
JO  - Scientific Reports
DO  - 10.1038/s41598-026-74562-9
UR  - https://www.nature.com/articles/s41598-026-74562-9
SN  - 2045-2322
ER  -